Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

1.32
BATS BZX Real-Time Price
As of 2:40pm ET
 -0.02 / -1.49%
Today’s Change
0.99
Today|||52-Week Range
6.60
-62.86%
Year-to-Date
No recent news for Neuralstem Inc.

Today’s Trading

Previous close1.34
Today’s open1.35
Day’s range1.32 - 1.43
Volume5,604
Average volume (3 months)513,002
Market cap$16.2M
Dividend yield--
Data as of 2:40pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+15.55%
Earnings growth (this year)-1,061.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+55.96%
P/E ratioNM
Price/Sales1,825.89
Price/Book1.31

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...-0.01-1.00%
RXIIRxi Pharmaceuticals ...+0.04+7.95%
NDRAENDRA Life Sciences ...+0.08+2.61%
VTGNVistaGen Therapeutic...+0.05+3.93%
Data as of 2:26pm ET, 10/18/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$6.50
Annual revenue (last year)$16.2K
Annual profit (last year)-$21.1M
Net profit margin-129,721.85%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, Chief Executive Officer &
CFO
Richard J. Daly
Chief Scientific Officer
Karl Y. Johe
Corporate headquarters
Germantown, Maryland

Forecasts